To analyse, if NOTCH3 −exon 16 was able to differentiate molecular subtypes of DLBCL, the expression were quantified in 75 clinical DLBCL samples using ddPCR and subtype associations were performed using unpaired t-test. This evidence concerns the gene NOTCH3 and diffuse large B-cell lymphoma.